1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CBR's leftover trash

Discussion in 'Ventana Medical Systems' started by Anonymous, Aug 22, 2013 at 12:52 AM.

  1. Anonymous

    Anonymous Guest

    Heard this place is just leftovers for CBR Trash. CBR is a shithole, this place im sure makes them feel better even though in the end they really arnt doing anything in terms of real science...